Catalysts for Fresenius Kabi USA LLC

Rocuronium Bromide Injection shortage — Hospira, Inc., a Pfizer Company

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

Fresenius Kabi USA, LLC recall (Cls II)

VALPROATE SODIUM — FDA approval

LIRAGLUTIDE — FDA approval

EPHEDRINE SULFATE — FDA approval

GLYCOPYRROLATE — FDA approval

FLUOROURACIL — FDA approval

FLUOROURACIL — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

GLYCOPYRROLATE — FDA approval

GLYCOPYRROLATE — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

Fresenius Kabi AG — KabiHelp® Uno; KabiHelp® Advance plus (510k cleared)

Novocol Pharmaceutical of Canada, Inc. recall (Cls II)

IDACIO (ADALIMUMAB-AACF) — FDA approval

EPHEDRINE SULFATE — FDA approval

MORPHINE SULFATE — FDA approval